$CLDX
Celldex Therapeutics, Inc
XNAS•Health Care•In Vitro & in Vivo Diagnostic Substances
$31.04
▲+0.11%+$0.035
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateCelldex Therapeutics, Inc
XNAS•Health Care•In Vitro & in Vivo Diagnostic Substances
Why is CLDX up today? It is at $31.04 (+0.11%), and our scanner flagged it 153 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CLDX spikes, and full due diligence on CLDX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $CLDX 153 times in the last 30 days. Create a free account to track $CLDX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on CLDX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CLDX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Martin Samuel Bates Officer | Other | 5K | added 17% | 33K | $50K at $10.38 | Jan 2, 26 |
Pepin Ronald Officer | Other | 19K 0.02% of company | added 100% | 20K | $54K at $2.78 | Dec 15, 25 |
Jimenez Freddy A. Officer | Sold (automatic/other) | -4K | sold 12% | 31K | $121K at $29.09 | Dec 4, 25 |
Wright Richard M. Other | Sold (automatic/other) | -49K 0.06% of company | sold 70% | 21K | $1.2M at $24.00 | Nov 13, 25 |
Wright Richard M. Other | Other | 49K 0.06% of company | added 100% | 70K | $445K at $9.02 | Nov 13, 25 |
Jimenez Freddy A. Officer | Sold (automatic/other) | -771 | sold 2.2% | 35K | $18K at $23.95 | Aug 13, 25 |
Marino James J Director | Sold (automatic/other) | -11K 0.01% of company | sold 83% | 2K | n/a | Nov 18, 24 |
Marucci Anthony S Officer | Bought (open market) | +12K 0.01% of company | added 40% | 40K | $308K at $26.82 | Nov 11, 24 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in in vitro & in vivo diagnostic substances, closest in size first.
Here is the latest on CLDX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CLDX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
CLDX last traded at $31.04, up 0.11% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Celldex Therapeutics, Inc (CLDX) is next expected to report earnings on Monday, November 9, 2026, about 34 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The CLDX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CLDX 153 times in the last 30 days.
CLDX (Celldex Therapeutics, Inc) trades on XNAS, with a market cap of about $2.43B in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CLDX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$CLDX discussion
Sign in to ask a question or join the discussion.